다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Therapeutic advances in gastroenterology, v.7 no.1, 2014년, pp.4 - 13
Emara, Mohamed H. , Mohamed, Salem Y. , Abdel-Aziz, Hesham R.
AI-Helper
Introduction:The eradication rate of Helicobacter pylori following the standard triple therapy is declining. This study was conducted to test whether the addition of Lactobacillus reuteri to the standard triple therapy improves the eradication rates as well as the clinical and pathological aspects i...
Afr Health Sci Abordin O. 143 7 2007
Byrd, James C., Yunker, Christopher K., Xu, Qin–Sheng, Sternberg, Lawrence R., Bresalier, Robert S.. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology, vol.118, no.6, 1072-1079.
CHAUVIERE, G., COCONNIER, M.-H., KERNEIS, S., FOURNIAT, J., SERVIN, A. L.. Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells. The Journal of general microbiology, vol.138, no.8, 1689-1696.
Cunningham-Rundles, Susanna, Ahrné, Siv, Bengmark, Stig, Johann-Liang, Rosemary, Marshall, Florence, Metakis, Linda, Califano, Claudia, Dunn, Ann-Margaret, Grassey, Claudia, Hinds, Gilberto, Cervia, Joseph. Probiotics and immune response. The American journal of gastroenterology : official publication of the National Gastroenterological Association, vol.95, no.1, S22-S25.
De Francesco, V., Zullo, A., Hassan, C., Valle, N.Della, Pietrini, L., Minenna, M.F., Winn, S., Monno, R., Stoppino, V., Morini, S., Panella, C., Ierardi, E.. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol.36, no.5, 322-326.
Efrati, Cesare, Nicolini, Giorgia, Cannaviello, Claudio, O'Sed, Nicole Piazza, Valabrega, Stefano. Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation.. World journal of gastroenterology : WJG, vol.18, no.43, 6250-6254.
Felley, Christian P., Corthésy-Theulaz, Irène, Rivero, Jose-Luis Blanco, Sipponen, Pentti, Kaufmann, Martin, Bauerfeind, Peter, Wiesel, Paul H., Brassart, Dominique, Pfeifer, Andrea, Blum, André L., Michetti, Pierre. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. European journal of gastroenterology & hepatology, vol.13, no.1, 25-29.
Francavilla, Ruggiero, Lionetti, Elena, Castellaneta, Stefania Paola, Magistà, Anna Maria, Maurogiovanni, Giovanni, Bucci, Nunzia, De Canio, Angela, Indrio, Flavia, Cavallo, Luciano, Ierardi, Enzo, Miniello, Vito Leonardo. Inhibition of Helicobacter pylori Infection in Humans by Lactobacillus reuteri ATCC 55730 and Effect on Eradication Therapy: A Pilot Study. Helicobacter, vol.13, no.2, 127-134.
Gill, H. S., Rutherfurd, K. J., Prasad, J., Gopal, P. K.. Enhancement of natural and acquired immunity byLactobacillus rhamnosus(HN001),Lactobacillus acidophilus(HN017) andBifidobacterium lactis(HN019). The British journal of nutrition, vol.83, no.2, 167-176.
Godoy, Anita Paula Ortiz, Ribeiro, Marcelo Lima, Benvengo, Yune Helena Borges, Vitiello, Lea, Miranda, Maira de Carvalho Bueno, Mendonça, Sergio, Pedrazzoli Jr, José. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC gastroenterology, vol.3, 20-20.
Graham, David Y., Opekun, Antone R., Klein, Peter D.. Clarithromycin for the Eradication of Helicobacter Pylori :. Journal of clinical gastroenterology, vol.16, no.4, 292-294.
Hamilton-Miller, J.M.T. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. International journal of antimicrobial agents, vol.22, no.4, 360-366.
J Gastrointestin Liver Dis Hunt R. 299 20 2011
Life Sci J Ibrahim N. 249 9 2012
Johnston, BC, Supina, AL, Ospina, M, Vohra, S. Cochrane review: Probiotics for the prevention of pediatric antibiotic‐associated diarrhea. Evidence-based child health : a Cochrane review journal, vol.3, no.2, 280-315.
Kim, Jung Mogg, Kim, Joo Sung, Kim, Nayoung, Kim, Sang Gyun, Jung, Hyun Chae, Song, In Sung. Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. International journal of antimicrobial agents, vol.28, no.1, 6-13.
LIONETTI, E., MINIELLO, V. L., CASTELLANETA, S. P., MAGISTÁ, A. M., DE CANIO, A., MAUROGIOVANNI, G., IERARDI, E., CAVALLO, L., FRANCAVILLA, R.. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Alimentary pharmacology & therapeutics, vol.24, no.10, 1461-1468.
Mack, David R., Michail, Sonia, Wei, Shu, McDougall, Laura, Hollingsworth, Michael A.. Probiotics inhibit enteropathogenicE. coliadherence in vitro by inducing intestinal mucin gene expression. American journal of physiology, Gastrointestinal and liver physiology, vol.276, no.4, G941-G950.
Manfredi, Marco, Bizzarri, Barbara, Sacchero, Roberto Igino, Maccari, Sergio, Calabrese, Lorenzo, Fabbian, Fabio, de’Angelis, Gian Luigi. Helicobacter pylori Infection in Clinical Practice: Probiotics and a Combination of Probiotics + Lactoferrin Improve Compliance, But Not Eradication, in Sequential Therapy. Helicobacter, vol.17, no.4, 254-263.
Marshall, Barry J., Armstrong, J.A., Francis, Graham J., Nokes, N.T., Wee, S.H.. Antibacterial Action of Bismuth in Relation to Campylobacter pyloridis Colonization and Gastritis. Digestion, vol.37, no.2, 16-30.
Megraud, Francis, Coenen, Samuel, Versporten, Ann, Kist, Manfred, Lopez-Brea, Manuel, Hirschl, Alexander M, Andersen, Leif P, Goossens, Herman, Glupczynski, Youri. Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut: journal of the British Society of Gastroenterology, vol.62, no.1, 34-42.
Mégraud, Francis, Lehours, Philippe. Helicobacter pyloriDetection and Antimicrobial Susceptibility Testing. Clinical microbiology reviews, vol.20, no.2, 280-322.
Afr J Pharm Pharmacol Njume C. 685 3 2009
Ojetti, Veronica, Bruno, Giovanni, Ainora, Maria Elena, Gigante, Giovanni, Rizzo, Gianluca, Roccarina, Davide, Gasbarrini, Antonio. Impact of Lactobacillus reuteri Supplementation on Anti- Helicobacter pylori Levofloxacin-Based Second-Line Therapy. Gastroenterology Research and Practice, vol.2012, 740381-.
Pantoflickova, D., Corthésy-Theulaz, I., Dorta, G., Stolte, M., Isler, P., Rochat, F., Enslen, M., Blum, A. L.. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Alimentary pharmacology & therapeutics, vol.18, no.8, 805-813.
Price, A., Misiewicz, J.J.. Sydney classification for gastritis. The Lancet, vol.337, no.8734, 174-.
MedGenMed Romano M. 19 6 2004
Eur Rev Med Pharmacol Sci Scaccianoce G. 251 12 2008
10.3855/jidc.512
Spinler, Jennifer K., Taweechotipatr, Malai, Rognerud, Cheryl L., Ou, Ching N., Tumwasorn, Somying, Versalovic, James. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe, vol.14, no.3, 166-171.
Z Gastroenterol Stolte M. 198 33 1995
Svedlund, Jan, Sj�din, Ingemar, Dotevall, Gerhard. GSRS?A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Digestive diseases and sciences, vol.33, no.2, 129-134.
Thomas, Carissa M., Hong, Teresa, van Pijkeren, Jan Peter, Hemarajata, Peera, Trinh, Dan V., Hu, Weidong, Britton, Robert A., Kalkum, Markus, Versalovic, James. Histamine Derived from Probiotic Lactobacillus reuteri Suppresses TNF via Modulation of PKA and ERK Signaling. PloS one, vol.7, no.2, e31951-.
THYAGARAJAN, SP, RAY, PALLAB, DAS, BIMAL KUMAR, AYYAGARI, ARCHANA, KHAN, ALEEM AHMED, DHARMALINGAM, S, RAO, USHA ANAND, RAJASAMBANDAM, P, RAMATHILAGAM, B, BHASIN, DEEPAK, SHARMA, MP, NAIK, SR, HABIBULLAH, CM. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study. Journal of gastroenterology and hepatology, vol.18, no.12, 1373-1378.
Vaira, D., Gatta, L., Ricci, C., D'Anna, L., Miglioli, M.. Helicobacter pylori: diseases, tests and treatment. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol.33, no.9, 788-794.
Vakil, Nimish, Hahn, Beth, McSorley, D.. Clarithromycin-resistant helicobacter pylori in patients with duodenal ulcer in the united states. The American journal of gastroenterology : official publication of the National Gastroenterological Association, vol.93, no.9, 1432-1435.
Biocell Vitini E. 223 24 2000
Am J Clin Nutr Wang K. 737 80 2004 10.1093/ajcn/80.3.649
YASAR, Bulent, ABUT, Evren, KAYADIBI, Huseyin, TOROS, Burak, SEZIKLI, Mesut, AKKAN, Zuleyha, KESKIN, Ozcan, OVUNC KURDAS, Oya. Efficacy of probiotics in Helicobacter pylori eradication therapy. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, vol.21, no.3, 212-217.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.